The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125003195 12500319 5 F 2016 20160811 20160627 20160817 PER US-PFIZER INC-2016249951 PFIZER 60.00 YR M Y 94.00000 KG 20160817 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125003195 12500319 1 PS SUTENT SUNITINIB MALATE 1 50 MG, CYCLIC(2 WEEKS ON/1 WEEK OFF) N 21938 50 MG CAPSULE, HARD
125003195 12500319 2 SS SUTENT SUNITINIB MALATE 1 50 MG, CYCLIC (28 DAYS ON/14DAYS OFF) N 21938 50 MG CAPSULE, HARD
125003195 12500319 3 SS SUTENT SUNITINIB MALATE 1 50 MG, CYCLIC (2 WEEKS ON / 1WEEK OFF) N 21938 50 MG CAPSULE, HARD
125003195 12500319 4 C SOTALOL. SOTALOL 1 UNK 0
125003195 12500319 5 C COZAAR LOSARTAN POTASSIUM 1 UNK 0
125003195 12500319 6 C FENOFIBRATE. FENOFIBRATE 1 UNK 0
125003195 12500319 7 C VYTORIN EZETIMIBESIMVASTATIN 1 UNK 0
125003195 12500319 8 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 UNK 0
125003195 12500319 9 C WARFARIN WARFARIN 1 UNK 0
125003195 12500319 10 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 UNK 0
125003195 12500319 11 C FLUTICASONE FLUTICASONEFLUTICASONE PROPIONATE 1 UNK 0
125003195 12500319 12 C TUSSIN CF DEXTROMETHORPHAN HYDROBROMIDEGUAIFENESINPHENYLEPHRINE HYDROCHLORIDE 1 UNK 0
125003195 12500319 13 C METFORMIN METFORMIN HYDROCHLORIDE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125003195 12500319 1 Metastatic renal cell carcinoma

Outcome of event

Event ID CASEID OUTC COD
125003195 12500319 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125003195 12500319 Abdominal discomfort
125003195 12500319 Abdominal pain upper
125003195 12500319 Blood pressure increased
125003195 12500319 Blood urine present
125003195 12500319 Cough
125003195 12500319 Disease progression
125003195 12500319 Dry skin
125003195 12500319 Dyspnoea
125003195 12500319 Fatigue
125003195 12500319 Feeling abnormal
125003195 12500319 Frequent bowel movements
125003195 12500319 Haematochezia
125003195 12500319 Haemoglobin decreased
125003195 12500319 Haemorrhoids
125003195 12500319 Headache
125003195 12500319 Metastatic renal cell carcinoma
125003195 12500319 Muscle spasms
125003195 12500319 Nausea
125003195 12500319 Neuralgia
125003195 12500319 Pain
125003195 12500319 Pain in extremity
125003195 12500319 Palmar-plantar erythrodysaesthesia syndrome
125003195 12500319 Platelet count decreased
125003195 12500319 Rash macular
125003195 12500319 Skin exfoliation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125003195 12500319 1 20160506 201605 0
125003195 12500319 2 20160527 0
125003195 12500319 3 20160624 0